277 related articles for article (PubMed ID: 21116311)
1. Innate immunity and cardiac allograft rejection.
Millington TM; Madsen JC
Kidney Int Suppl; 2010 Dec; (119):S18-21. PubMed ID: 21116311
[TBL] [Abstract][Full Text] [Related]
2. Innate immunity and resistance to tolerogenesis in allotransplantation.
Benichou G; Tonsho M; Tocco G; Nadazdin O; Madsen JC
Front Immunol; 2012; 3():73. PubMed ID: 22566954
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity in heart transplantation.
Millington TM; Madsen JC
Curr Opin Organ Transplant; 2009 Oct; 14(5):571-6. PubMed ID: 19542889
[TBL] [Abstract][Full Text] [Related]
4. Immunology insights into cardiac allograft rejection.
Savasta M; Lentini S
Rev Cardiovasc Med; 2011; 12(2):e68-76. PubMed ID: 21796085
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of chronic cardiac allograft rejection.
Costello JP; Mohanakumar T; Nath DS
Tex Heart Inst J; 2013; 40(4):395-9. PubMed ID: 24082367
[TBL] [Abstract][Full Text] [Related]
6. Roles of toll-like receptors signaling in organ transplantation.
Li T; Chen G; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells play a critical role in cardiac allograft vasculopathy in an interleukin-6--dependent manner.
Zhang ZX; Huang X; Jiang J; Lian D; Min WP; Liu W; Haig A; Jevnikar AM
Transplantation; 2014 Nov; 98(10):1029-39. PubMed ID: 25286056
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of chronic rejection in heart transplantation: important elements of pathogenesis and future treatments.
Suzuki J; Isobe M; Morishita R; Nagai R
Circ J; 2010 Feb; 74(2):233-9. PubMed ID: 20009354
[TBL] [Abstract][Full Text] [Related]
9. [Role of innate immunity in tolerance induction].
Dolgikh MS
Biomed Khim; 2015; 61(5):560-78. PubMed ID: 26539864
[TBL] [Abstract][Full Text] [Related]
10. Cardiac allograft vasculopathy: current review and future research directions.
Pober JS; Chih S; Kobashigawa J; Madsen JC; Tellides G
Cardiovasc Res; 2021 Nov; 117(13):2624-2638. PubMed ID: 34343276
[TBL] [Abstract][Full Text] [Related]
11. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts.
Uehara S; Chase CM; Kitchens WH; Rose HS; Colvin RB; Russell PS; Madsen JC
J Immunol; 2005 Sep; 175(5):3424-30. PubMed ID: 16116237
[TBL] [Abstract][Full Text] [Related]
12. Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathology.
Zecher D; Li Q; Williams AL; Walters JT; Baddoura FK; Chalasani G; Rothstein DM; Shlomchik WD; Demetris AJ; Lakkis FG
Transpl Immunol; 2012 Mar; 26(2-3):113-8. PubMed ID: 22226941
[TBL] [Abstract][Full Text] [Related]
13. Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.
Paul P; Picard C; Sampol E; Lyonnet L; Di Cristofaro J; Paul-Delvaux L; Lano G; Nicolino-Brunet C; Ravis E; Collart F; Dignat-George F; Dussol B; Sabatier F; Mouly-Bandini A
Circulation; 2018 Mar; 137(10):1049-1059. PubMed ID: 29097449
[TBL] [Abstract][Full Text] [Related]
14. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
Goldstein DR; Palmer SM
J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
[TBL] [Abstract][Full Text] [Related]
15. Impact of innate and adaptive immunity on rejection and tolerance.
Kim IK; Bedi DS; Denecke C; Ge X; Tullius SG
Transplantation; 2008 Oct; 86(7):889-94. PubMed ID: 18852649
[TBL] [Abstract][Full Text] [Related]
16. The innate immune response to allotransplants: mechanisms and therapeutic potentials.
Ochando J; Ordikhani F; Boros P; Jordan S
Cell Mol Immunol; 2019 Apr; 16(4):350-356. PubMed ID: 30804476
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors, innate immunity and lung transplantation.
Snyder LD; Palmer SM
Front Biosci (Elite Ed); 2009 Jun; 1(2):600-4. PubMed ID: 19482676
[TBL] [Abstract][Full Text] [Related]
18. Innate immunity in transplant tolerance and rejection.
Murphy SP; Porrett PM; Turka LA
Immunol Rev; 2011 May; 241(1):39-48. PubMed ID: 21488888
[TBL] [Abstract][Full Text] [Related]
19. Microbiota in heart and lung transplantation: implications for innate-adaptive immune interface.
Bai YZ; Roberts SH; Kreisel D; Nava RG
Curr Opin Organ Transplant; 2021 Dec; 26(6):609-614. PubMed ID: 34561360
[TBL] [Abstract][Full Text] [Related]
20. Predicting the development of cardiac allograft vasculopathy.
Seki A; Fishbein MC
Cardiovasc Pathol; 2014; 23(5):253-60. PubMed ID: 24972526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
